Cargando…

GLP-1(28-36)amide, a Long Ignored Peptide Revisited

Glucagon-like peptide-1 (GLP-1), which has been extensively applied for treating type 2 diabetes mellitus (T2DM), is an incretin hormone that regulates glucose homeostasis. GLP-1(28-36)amide, a C-terminal nonapeptide (FIAWLVKGRamide) of GLP-1, is a major product derived from the cleavage of GLP-1 by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Bilan, Ji, Kaige, Peng, Anlin, Yang, Xin, Huang, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293754/ https://www.ncbi.nlm.nih.gov/pubmed/25598850 http://dx.doi.org/10.2174/1874091X01408010107

Ejemplares similares

GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?
por: Taing, Meng-Wong, et al.
Publicado: (2014)

Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012)

Combination of Peptide YY(3–36) with GLP-1(7–36 amide) Causes an Increase in First-Phase Insulin Secretion after IV Glucose
por: Tan, Tricia M., et al.
Publicado: (2014)

Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1’s better half?
por: Liu, Yangyang, et al.
Publicado: (2020)

The Gut Hormones PYY(3-36) and GLP-1(7-36 amide) Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans
por: De Silva, Akila, et al.
Publicado: (2011)

Acute effects of glucagon‐like peptide‐1, GLP‐1(9–36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
por: Bremholm, Lasse, et al.
Publicado: (2017)

GLP-1 (7–36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles
por: Chen, Melissa, et al.
Publicado: (2014)

GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice
por: Tomas, Eva, et al.
Publicado: (2015)

Ingestion of coffee polyphenols increases postprandial release of the active glucagon-like peptide-1 (GLP-1(7–36)) amide in C57BL/6J mice
por: Fujii, Yoshie, et al.
Publicado: (2015)

Ignoring Non-ignorable Missingness
por: Rabe-Hesketh, Sophia, et al.
Publicado: (2022)

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects
por: Sathananthan, Matheni, et al.
Publicado: (2013)

Ignorism
por: Trüeb, Ralph Michel
Publicado: (2023)

Recombinant Expression and Stapling of a Novel Long-Acting GLP-1R Peptide Agonist
por: Lear, Sam, et al.
Publicado: (2020)

meso-3,6-Dioxopiperazine-2,5-diacetamide
por: Li, Ping, et al.
Publicado: (2011)

Ignoring steroids
por: Van Epps, Heather L.
Publicado: (2006)

Ignoring endotoxin
por: Van Epps, Heather L.
Publicado: (2006)

Ignore the Hype
por: Perry, Brian
Publicado: (2020)

The encyclopaedia of ignorance
por: Weston-Smith, M, et al.
Publicado: (1977)

The encyclopaedia of ignorance
por: Weston-Smith, M, et al.
Publicado: (1977)

Conspiracy of Ignorance
Publicado: (1968)

Ignorance and Disease
Publicado: (1871)

Ignorance and Health
Publicado: (1880)

Ignorance : A case for scepticism
por: Unger, Peter
Publicado: (1975)

Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019)

Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists
por: Umapathysivam, Mahesh M, et al.
Publicado: (2023)

Novel insights into peptide amidation and amidating activity in the human circulation
por: Kaufmann, Paul, et al.
Publicado: (2021)

The effect of amidation on the behaviour of antimicrobial peptides
por: Mura, Manuela, et al.
Publicado: (2016)

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects. Diabetes 2013;62:2752–2756
por: Sathananthan, M, et al.
Publicado: (2013)

Ignorability for general longitudinal data
por: Farewell, D. M., et al.
Publicado: (2017)

Signalling pathways activated by glucagon-like peptide-1 (7-36) amide in the rat heart and their role in protection against ischaemia
por: Huisamen, Barbara, et al.
Publicado: (2008)

Emetic Response to T-2 Toxin Correspond to Secretion of Glucagon-like Peptide-(17)(–36) Amide and Glucose-Dependent Insulinotropic Polypeptide
por: Zhang, Jie, et al.
Publicado: (2022)

Substance P and Glucagon-like Peptide-1(7-36) Amide Mediate Anorexic Responses to Trichothecene Deoxynivalenol and Its Congeners
por: Jia, Hui, et al.
Publicado: (2022)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis
por: Jin, Yue, et al.
Publicado: (2015)

Poverty and COVID-19: an ignored factor
por: Peng, Yinglong., et al.
Publicado: (2022)

Venous stroke–a stroke subtype that should not be ignored
por: Zhou, Yifan, et al.
Publicado: (2022)

Embrace Your Ignorance
por: Schrage, Michael
Publicado: (2015)

Malassezia—Can it be Ignored?
por: Thayikkannu, Ambujavalli Balakrishnan, et al.
Publicado: (2015)

Osteochondroma: ignore or investigate?()
por: de Souza, Antônio Marcelo Gonçalves, et al.
Publicado: (2014)

The Dangers of Ignorance at Portsmouth
Publicado: (1912)

Cannot write session to /tmp/vufind_sessions/sess_0hfseihmd9rrogpj0hb5tlohja